- Georges GAUDRIAULT, Scientific Director of DEINOVE, will give a talk at the ECCMID, at the ‘Therapeutics pipeline corner’, on this coming Sunday, April 14th, in Amsterdam.
- He will describe the progress of the DNV3837 program, including new data and the design of the upcoming Phase II clinical trial in severe gastrointestinal infections caused by Clostridium difficile.
- ECCMID is the world’s premier Clinical Microbiology & Infectious Diseases event.
DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients, announced that Georges GAUDRIAULT will give a presentation at the 29th Annual Congress of the European Society of Clinical Microbiology and Infectious Diseases (ECCMID, Amsterdam, the Netherlands, from 13 April to 16 April).
Full PR available here